TW200307544A - Imidazole compound, production method thereof and use thereof - Google Patents
Imidazole compound, production method thereof and use thereof Download PDFInfo
- Publication number
- TW200307544A TW200307544A TW092116056A TW92116056A TW200307544A TW 200307544 A TW200307544 A TW 200307544A TW 092116056 A TW092116056 A TW 092116056A TW 92116056 A TW92116056 A TW 92116056A TW 200307544 A TW200307544 A TW 200307544A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- fluorenyl
- ethyl acetate
- substituent
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002175086 | 2002-06-14 | ||
| JP2003041085 | 2003-02-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200307544A true TW200307544A (en) | 2003-12-16 |
Family
ID=29738411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW092116056A TW200307544A (en) | 2002-06-14 | 2003-06-13 | Imidazole compound, production method thereof and use thereof |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7410981B2 (pl) |
| EP (2) | EP1513527B1 (pl) |
| JP (1) | JPWO2003106429A1 (pl) |
| KR (1) | KR20050009751A (pl) |
| CN (1) | CN1678315A (pl) |
| AR (1) | AR040221A1 (pl) |
| AT (1) | ATE437642T1 (pl) |
| AU (2) | AU2003242390A1 (pl) |
| BR (1) | BR0311801A (pl) |
| CA (2) | CA2489361A1 (pl) |
| DE (1) | DE60328603D1 (pl) |
| IL (1) | IL165562A0 (pl) |
| MX (1) | MXPA04012396A (pl) |
| NO (1) | NO20050141L (pl) |
| OA (1) | OA12867A (pl) |
| PE (1) | PE20040563A1 (pl) |
| PL (1) | PL373085A1 (pl) |
| TW (1) | TW200307544A (pl) |
| WO (2) | WO2003106429A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1740571T3 (da) | 2004-04-28 | 2009-11-02 | Hetero Drugs Ltd | Fremgangsmåde til fremstilling af pyridinylmethyl-1H-benzimidazolforbindelser i enantiomerisk beriget form eller som enkelte enantiomerer |
| WO2006090845A1 (ja) | 2005-02-25 | 2006-08-31 | Takeda Pharmaceutical Company Limited | 顆粒の製造方法 |
| KR101148399B1 (ko) * | 2005-06-22 | 2012-05-23 | 일양약품주식회사 | 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물 |
| US20100317689A1 (en) * | 2006-09-19 | 2010-12-16 | Garst Michael E | Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
| MX2009004475A (es) | 2006-10-27 | 2009-08-12 | Univ Missouri | Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma. |
| CA2716367C (en) | 2008-02-20 | 2015-05-26 | The Curators Of The University Of Missouri | Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same |
| CA2778115C (en) | 2009-10-28 | 2016-04-05 | Newlink Genetics Corporation | Imidazole derivatives as ido inhibitors |
| US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
| US10301254B2 (en) | 2015-04-23 | 2019-05-28 | Temple University—Of the Commonwealth System of Higher Education | Substituted polycationic multi-quaternary ammonium salts as antimicrobial agents |
| BR112018076244A2 (pt) | 2016-06-21 | 2019-03-26 | The Trustees Of Columbia University In The City Of New York | inibidores da aldose redutase e métodos de uso destes |
| US11111216B2 (en) | 2016-10-26 | 2021-09-07 | Temple University-Of The Commonwealth System Of Higher Education | Polycationic amphiphiles as antimicrobial agents and methods using same |
| RU2020107188A (ru) | 2017-07-28 | 2021-08-30 | Эпплайд Терапьютикс Инк. | Композиции и способы лечения галактоземии |
| KR20210156235A (ko) * | 2020-06-17 | 2021-12-24 | 일동제약(주) | 신규한 산 분비 억제제 및 이의 용도 |
| IT202200001022A1 (it) * | 2022-01-21 | 2023-07-21 | Exo Lab Italia | Composti farmaceutici ibridi ottenuti mediante coniugazione di un inibitore delle pompe protoniche e un inibitore delle anidrasi carboniche |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE416649B (sv) | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
| SE8300736D0 (sv) | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
| KR890000387B1 (ko) | 1984-09-24 | 1989-03-16 | 디 엎존 캄파니 | 2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법 |
| IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
| SE8505112D0 (sv) | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
| US4965269A (en) | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
| US5614549A (en) * | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
| US6542966B1 (en) * | 1998-07-16 | 2003-04-01 | Intel Corporation | Method and apparatus for managing temporal and non-temporal data in a single cache structure |
| DE19832060C2 (de) * | 1998-07-16 | 2000-07-06 | Siemens Ag | Doppelbare Prozessoreinrichtung |
| US6093734A (en) | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
| PL352834A1 (pl) * | 1999-04-09 | 2003-09-08 | Abbott Gmbh & Co.Kg | Proleki inhibitorów trombiny |
| US6765019B1 (en) * | 1999-05-06 | 2004-07-20 | University Of Kentucky Research Foundation | Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| WO2002004448A2 (en) * | 2000-07-07 | 2002-01-17 | Neotherapeutics, Inc. | Methods for treatment of drug-induced peripheral neuropathy and related conditions |
| WO2002030920A1 (fr) | 2000-10-12 | 2002-04-18 | Takeda Chemical Industries, Ltd. | Composes derives de benzimidazole, leur procede de production et leur utilisation |
| WO2002096910A1 (en) * | 2001-05-31 | 2002-12-05 | Medarex, Inc. | Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| US20040248941A1 (en) | 2001-09-25 | 2004-12-09 | Keiji Kamiyama | Benzimidazone compound, process for producing the same, and use thereof |
-
2003
- 2003-06-13 US US10/517,633 patent/US7410981B2/en not_active Expired - Fee Related
- 2003-06-13 AU AU2003242390A patent/AU2003242390A1/en not_active Abandoned
- 2003-06-13 DE DE60328603T patent/DE60328603D1/de not_active Expired - Lifetime
- 2003-06-13 PE PE2003000593A patent/PE20040563A1/es not_active Application Discontinuation
- 2003-06-13 WO PCT/JP2003/007545 patent/WO2003106429A1/ja active Application Filing
- 2003-06-13 KR KR10-2004-7020371A patent/KR20050009751A/ko not_active Application Discontinuation
- 2003-06-13 BR BR0311801-0A patent/BR0311801A/pt not_active IP Right Cessation
- 2003-06-13 AR ARP030102114A patent/AR040221A1/es not_active Application Discontinuation
- 2003-06-13 US US10/517,847 patent/US20060293371A1/en not_active Abandoned
- 2003-06-13 CA CA002489361A patent/CA2489361A1/en not_active Abandoned
- 2003-06-13 EP EP03733426A patent/EP1513527B1/en not_active Expired - Lifetime
- 2003-06-13 AU AU2003242388A patent/AU2003242388A1/en not_active Abandoned
- 2003-06-13 JP JP2004513262A patent/JPWO2003106429A1/ja active Pending
- 2003-06-13 PL PL03373085A patent/PL373085A1/pl not_active Application Discontinuation
- 2003-06-13 EP EP03733425A patent/EP1514870A4/en not_active Withdrawn
- 2003-06-13 TW TW092116056A patent/TW200307544A/zh unknown
- 2003-06-13 WO PCT/JP2003/007546 patent/WO2003105845A1/en active Application Filing
- 2003-06-13 OA OA1200400327A patent/OA12867A/en unknown
- 2003-06-13 AT AT03733426T patent/ATE437642T1/de not_active IP Right Cessation
- 2003-06-13 CA CA002489470A patent/CA2489470A1/en not_active Abandoned
- 2003-06-13 CN CNA038188953A patent/CN1678315A/zh active Pending
- 2003-06-13 MX MXPA04012396A patent/MXPA04012396A/es not_active Application Discontinuation
-
2004
- 2004-12-05 IL IL16556204A patent/IL165562A0/xx unknown
-
2005
- 2005-01-11 NO NO20050141A patent/NO20050141L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003242390A1 (en) | 2003-12-31 |
| US7410981B2 (en) | 2008-08-12 |
| CN1678315A (zh) | 2005-10-05 |
| EP1514870A4 (en) | 2006-08-23 |
| EP1513527A1 (en) | 2005-03-16 |
| ATE437642T1 (de) | 2009-08-15 |
| PE20040563A1 (es) | 2004-10-21 |
| EP1513527B1 (en) | 2009-07-29 |
| MXPA04012396A (es) | 2005-06-17 |
| WO2003105845A1 (en) | 2003-12-24 |
| IL165562A0 (en) | 2006-01-15 |
| KR20050009751A (ko) | 2005-01-25 |
| CA2489470A1 (en) | 2003-12-24 |
| AU2003242388A1 (en) | 2003-12-31 |
| DE60328603D1 (de) | 2009-09-10 |
| BR0311801A (pt) | 2005-04-12 |
| US20050222210A1 (en) | 2005-10-06 |
| AR040221A1 (es) | 2005-03-16 |
| NO20050141L (no) | 2005-01-27 |
| OA12867A (en) | 2006-09-15 |
| NO20050141D0 (no) | 2005-01-11 |
| US20060293371A1 (en) | 2006-12-28 |
| WO2003106429A1 (ja) | 2003-12-24 |
| JPWO2003106429A1 (ja) | 2005-10-13 |
| CA2489361A1 (en) | 2003-12-24 |
| PL373085A1 (pl) | 2005-08-08 |
| EP1514870A1 (en) | 2005-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI378794B (en) | Controlled release solid preparation | |
| TWI669297B (zh) | 稠合雜環化合物 | |
| US10023544B2 (en) | Heterocyclic compound | |
| TW200307544A (en) | Imidazole compound, production method thereof and use thereof | |
| DE19624659A1 (de) | Neue Pyridylalken- und Pyridylalkinsäureamide | |
| CN110678458A (zh) | 用于治疗代谢紊乱的经取代的环基-乙酸衍生物 | |
| TWI648276B (zh) | 雜環化合物 | |
| WO2004082665A1 (ja) | 放出制御組成物 | |
| WO2002030920A1 (fr) | Composes derives de benzimidazole, leur procede de production et leur utilisation | |
| WO2004080439A1 (ja) | 高濃度に活性成分を球形核に付着させた医薬組成物 | |
| US20170349605A1 (en) | Condensed heterocyclic compound | |
| TWI668214B (zh) | 具有sstr5拮抗作用之雜環化合物 | |
| EP2970331A1 (en) | Spiro azetidine isoxazole derivatives and their use as sstr5 antagonists | |
| CN100364989C (zh) | 拉唑类衍生物及其盐和用途 | |
| JP2006501313A (ja) | （ｓ）−パントプラゾールの塩及びその水和物 | |
| KR20220024617A (ko) | 리디닐라졸 및 이의 결정 형태의 제조방법 | |
| BR112021009270A2 (pt) | sal de potássio mono-hidratado de um derivado de tienopiridona e seu processo de preparação | |
| CN111662239B (zh) | 1,2,4-三唑类化合物及其制法和药物用途 | |
| CA3169000A1 (en) | Crystal of imidazopyridinone compound or salt thereof | |
| JP2002187890A (ja) | ベンズイミダゾール化合物、その製造法およびその用途 | |
| CN118206569A (zh) | 唑啉铵喹啉甲酰胺类似物及其药物组合物、制备方法和医药用途 | |
| JP2008115173A (ja) | スルフィニルベンズイミダゾール化合物の塩およびそれらの結晶ならびに非晶質体 | |
| JP2004307457A (ja) | イミダゾール化合物、その製造方法およびその用途 | |
| US20080070942A1 (en) | Prazole derivatives and salts thereof and use of same | |
| JPH02290878A (ja) | ベンゾチエノ（フロ）ピリジン誘導体 |